TY - JOUR
T1 - Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis
AU - Makragiannis, Georgios
AU - Vahdani, Kaveh
AU - Carreño, Ester
AU - Lee, Richard W.J.
AU - Dick, Andrew D.
AU - Ross, Adam H.
PY - 2018/4/1
Y1 - 2018/4/1
N2 - Purpose: To report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab. Methods: Case report. Results: A 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the left eye. The patient was investigated with ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT). Following initial treatment, fundus examination, fluorescein angiography, and OCT of the right eye revealed a secondary juxtafoveal classic choroidal neovascularization. Following a single intravitreal injection of bevacizumab, the patient had excellent visual recovery, with absence of subretinal or intraretinal fluid in the OCT. Conclusions: Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.
AB - Purpose: To report a case of juxtafoveal choroidal neovascularization in a patient with candida chorioretinitis successfully treated with intravitreal bevacizumab. Methods: Case report. Results: A 45-year-old woman previously treated for candida chorioretinitis was presented with reduced vision in the left eye. The patient was investigated with ophthalmoscopy, fluorescein angiography, and optical coherence tomography (OCT). Following initial treatment, fundus examination, fluorescein angiography, and OCT of the right eye revealed a secondary juxtafoveal classic choroidal neovascularization. Following a single intravitreal injection of bevacizumab, the patient had excellent visual recovery, with absence of subretinal or intraretinal fluid in the OCT. Conclusions: Bevacizumab was effective in treatment of choroidal neovascularization associated with candida chorioretinitis.
KW - Bevacizumab
KW - Candida
KW - Chorioretinitis
KW - Choroidal neovascular membrane
UR - http://www.scopus.com/inward/record.url?scp=85016547330&partnerID=8YFLogxK
U2 - 10.1007/s10792-017-0502-x
DO - 10.1007/s10792-017-0502-x
M3 - Article (Academic Journal)
C2 - 28361379
SN - 0165-5701
VL - 38
SP - 781
EP - 785
JO - International Ophthalmology
JF - International Ophthalmology
IS - 2
ER -